Duke-West Virginia HCV Telemedicine Archived Webinar

 
This enduring material is designed to address access to adequate treatment of patients chronically infected with hepatitis C. Access to the appropriate hepatology expertise to administer complex treatment regimens is a key factor in treating these patients. 

Learning Objectives

At the conclusion of this activity, participants should be able to:

•          Describe the rationale behind the current screening recommendations for HCV

•          Identify the predictors of HCV treatment response with current therapies

•          Manage the adverse events of HCV treatment appropriately

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)
  • 0.00 Attendance
Registration Opens: 
10/01/2013
Registration Expires: 
09/30/2014

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)
  • 0.00 Attendance

Accreditation Period

Registration Opens: 
10/01/2013
Registration Expires: 
09/30/2014
Please login or register to take this course.